arrow
K

Keyur Patel

University Health Network
H指数:59
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sex differences in mortality risk profiles across the life course in metabolic dysfunction-associated steatotic liver disease: a machine learning analysis of the Canadian Longitudinal Study on Aging

代谢功能障碍相关脂肪性肝病生命历程中的死亡风险谱性别差异:加拿大老龄化纵向研究的机器学习分析

2026-10-050
OAAI
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease

代谢功能障碍或有代谢功能障碍相关脂肪性肝病的慢性乙型肝炎患者中,肝细胞癌及其他肝脏相关事件的预测

2025-09-090
OAAI
Characterizing the Representation of Different Global Regions and National Income-Levels Amongst Invited Speakers and Committee Members at Major International Spine Surgery Conferences

表征主要国际脊柱外科会议中受邀讲者与委员会成员中不同全球区域及国家收入水平的代表性

2025-05-160
OA
Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B

慢性乙型肝炎患者代谢合并症与肝纤维化严重程度及肝纤维化消退的关系。Clin. Gastroenterol. Hepatol, S1542-3565(25)00411-2

2025-05-150
OAAI
Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virus

超越《HIV器官政策公平法案》:利用携带人类免疫缺陷病毒的供体器官,为人类免疫缺陷病毒感染者扩大肾脏和肝脏移植的路线图

2025-05-120
PRE
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline

基于血液的生物标志物对慢性肝病肝纤维化分期的准确性: 支持AASLD实践指南的系统评价

2024-03-157
OA